Oral Antihypertensive Drug and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Oral Antihypertensive Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oral Antihypertensive Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oral Antihypertensive Drug Overall Market Size
2.1 Global Oral Antihypertensive Drug Market Size: 2022 VS 2029
2.2 Global Oral Antihypertensive Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oral Antihypertensive Drug Players in Global Market
3.2 Top Global Oral Antihypertensive Drug Companies Ranked by Revenue
3.3 Global Oral Antihypertensive Drug Revenue by Companies
3.4 Top 3 and Top 5 Oral Antihypertensive Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oral Antihypertensive Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oral Antihypertensive Drug Players in Global Market
3.6.1 List of Global Tier 1 Oral Antihypertensive Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Oral Antihypertensive Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oral Antihypertensive Drug Market Size Markets, 2022 & 2029
4.1.2 Diuretics
4.1.3 ?-blockers
4.1.4 Calcium Channel Blockers
4.1.5 Renin-angiotensin System Inhibitors
4.2 By Type - Global Oral Antihypertensive Drug Revenue & Forecasts
4.2.1 By Type - Global Oral Antihypertensive Drug Revenue, 2018-2023
4.2.2 By Type - Global Oral Antihypertensive Drug Revenue, 2024-2029
4.2.3 By Type - Global Oral Antihypertensive Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oral Antihypertensive Drug Market Size, 2022 & 2029
5.1.2 Online Pharmacy
5.1.3 Offline Pharmacy
5.2 By Application - Global Oral Antihypertensive Drug Revenue & Forecasts
5.2.1 By Application - Global Oral Antihypertensive Drug Revenue, 2018-2023
5.2.2 By Application - Global Oral Antihypertensive Drug Revenue, 2024-2029
5.2.3 By Application - Global Oral Antihypertensive Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Oral Antihypertensive Drug Market Size, 2022 & 2029
6.2 By Region - Global Oral Antihypertensive Drug Revenue & Forecasts
6.2.1 By Region - Global Oral Antihypertensive Drug Revenue, 2018-2023
6.2.2 By Region - Global Oral Antihypertensive Drug Revenue, 2024-2029
6.2.3 By Region - Global Oral Antihypertensive Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Oral Antihypertensive Drug Revenue, 2018-2029
6.3.2 US Oral Antihypertensive Drug Market Size, 2018-2029
6.3.3 Canada Oral Antihypertensive Drug Market Size, 2018-2029
6.3.4 Mexico Oral Antihypertensive Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Oral Antihypertensive Drug Revenue, 2018-2029
6.4.2 Germany Oral Antihypertensive Drug Market Size, 2018-2029
6.4.3 France Oral Antihypertensive Drug Market Size, 2018-2029
6.4.4 U.K. Oral Antihypertensive Drug Market Size, 2018-2029
6.4.5 Italy Oral Antihypertensive Drug Market Size, 2018-2029
6.4.6 Russia Oral Antihypertensive Drug Market Size, 2018-2029
6.4.7 Nordic Countries Oral Antihypertensive Drug Market Size, 2018-2029
6.4.8 Benelux Oral Antihypertensive Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Oral Antihypertensive Drug Revenue, 2018-2029
6.5.2 China Oral Antihypertensive Drug Market Size, 2018-2029
6.5.3 Japan Oral Antihypertensive Drug Market Size, 2018-2029
6.5.4 South Korea Oral Antihypertensive Drug Market Size, 2018-2029
6.5.5 Southeast Asia Oral Antihypertensive Drug Market Size, 2018-2029
6.5.6 India Oral Antihypertensive Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Oral Antihypertensive Drug Revenue, 2018-2029
6.6.2 Brazil Oral Antihypertensive Drug Market Size, 2018-2029
6.6.3 Argentina Oral Antihypertensive Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oral Antihypertensive Drug Revenue, 2018-2029
6.7.2 Turkey Oral Antihypertensive Drug Market Size, 2018-2029
6.7.3 Israel Oral Antihypertensive Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Oral Antihypertensive Drug Market Size, 2018-2029
6.7.5 UAE Oral Antihypertensive Drug Market Size, 2018-2029
7 Oral Antihypertensive Drug Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Oral Antihypertensive Drug Major Product Offerings
7.1.4 Novartis Oral Antihypertensive Drug Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Oral Antihypertensive Drug Major Product Offerings
7.2.4 Pfizer Oral Antihypertensive Drug Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Oral Antihypertensive Drug Major Product Offerings
7.3.4 Johnson & Johnson Oral Antihypertensive Drug Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Oral Antihypertensive Drug Major Product Offerings
7.4.4 Sanofi Oral Antihypertensive Drug Revenue in Global Market (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Lupin
7.5.1 Lupin Company Summary
7.5.2 Lupin Business Overview
7.5.3 Lupin Oral Antihypertensive Drug Major Product Offerings
7.5.4 Lupin Oral Antihypertensive Drug Revenue in Global Market (2018-2023)
7.5.5 Lupin Key News & Latest Developments
7.6 Ranbaxy Laboratories
7.6.1 Ranbaxy Laboratories Company Summary
7.6.2 Ranbaxy Laboratories Business Overview
7.6.3 Ranbaxy Laboratories Oral Antihypertensive Drug Major Product Offerings
7.6.4 Ranbaxy Laboratories Oral Antihypertensive Drug Revenue in Global Market (2018-2023)
7.6.5 Ranbaxy Laboratories Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Oral Antihypertensive Drug Major Product Offerings
7.7.4 Merck Oral Antihypertensive Drug Revenue in Global Market (2018-2023)
7.7.5 Merck Key News & Latest Developments
7.8 Astra Zeneca
7.8.1 Astra Zeneca Company Summary
7.8.2 Astra Zeneca Business Overview
7.8.3 Astra Zeneca Oral Antihypertensive Drug Major Product Offerings
7.8.4 Astra Zeneca Oral Antihypertensive Drug Revenue in Global Market (2018-2023)
7.8.5 Astra Zeneca Key News & Latest Developments
7.9 Daiichi Sankyo
7.9.1 Daiichi Sankyo Company Summary
7.9.2 Daiichi Sankyo Business Overview
7.9.3 Daiichi Sankyo Oral Antihypertensive Drug Major Product Offerings
7.9.4 Daiichi Sankyo Oral Antihypertensive Drug Revenue in Global Market (2018-2023)
7.9.5 Daiichi Sankyo Key News & Latest Developments
7.10 Takeda
7.10.1 Takeda Company Summary
7.10.2 Takeda Business Overview
7.10.3 Takeda Oral Antihypertensive Drug Major Product Offerings
7.10.4 Takeda Oral Antihypertensive Drug Revenue in Global Market (2018-2023)
7.10.5 Takeda Key News & Latest Developments
7.11 Actelion
7.11.1 Actelion Company Summary
7.11.2 Actelion Business Overview
7.11.3 Actelion Oral Antihypertensive Drug Major Product Offerings
7.11.4 Actelion Oral Antihypertensive Drug Revenue in Global Market (2018-2023)
7.11.5 Actelion Key News & Latest Developments
7.12 United Therapeutics
7.12.1 United Therapeutics Company Summary
7.12.2 United Therapeutics Business Overview
7.12.3 United Therapeutics Oral Antihypertensive Drug Major Product Offerings
7.12.4 United Therapeutics Oral Antihypertensive Drug Revenue in Global Market (2018-2023)
7.12.5 United Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Oral Antihypertensive Drug Market Opportunities & Trends in Global Market
Table 2. Oral Antihypertensive Drug Market Drivers in Global Market
Table 3. Oral Antihypertensive Drug Market Restraints in Global Market
Table 4. Key Players of Oral Antihypertensive Drug in Global Market
Table 5. Top Oral Antihypertensive Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Oral Antihypertensive Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Oral Antihypertensive Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Oral Antihypertensive Drug Product Type
Table 9. List of Global Tier 1 Oral Antihypertensive Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral Antihypertensive Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Oral Antihypertensive Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Oral Antihypertensive Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Oral Antihypertensive Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Oral Antihypertensive Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Oral Antihypertensive Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Oral Antihypertensive Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Oral Antihypertensive Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Oral Antihypertensive Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Oral Antihypertensive Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Oral Antihypertensive Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Oral Antihypertensive Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Oral Antihypertensive Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Oral Antihypertensive Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Oral Antihypertensive Drug Revenue, (US$, Mn), 2024-2029
Table 30. Novartis Company Summary
Table 31. Novartis Oral Antihypertensive Drug Product Offerings
Table 32. Novartis Oral Antihypertensive Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Oral Antihypertensive Drug Product Offerings
Table 36. Pfizer Oral Antihypertensive Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Johnson & Johnson Company Summary
Table 39. Johnson & Johnson Oral Antihypertensive Drug Product Offerings
Table 40. Johnson & Johnson Oral Antihypertensive Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Johnson & Johnson Key News & Latest Developments
Table 42. Sanofi Company Summary
Table 43. Sanofi Oral Antihypertensive Drug Product Offerings
Table 44. Sanofi Oral Antihypertensive Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Sanofi Key News & Latest Developments
Table 46. Lupin Company Summary
Table 47. Lupin Oral Antihypertensive Drug Product Offerings
Table 48. Lupin Oral Antihypertensive Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Lupin Key News & Latest Developments
Table 50. Ranbaxy Laboratories Company Summary
Table 51. Ranbaxy Laboratories Oral Antihypertensive Drug Product Offerings
Table 52. Ranbaxy Laboratories Oral Antihypertensive Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Ranbaxy Laboratories Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Oral Antihypertensive Drug Product Offerings
Table 56. Merck Oral Antihypertensive Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Merck Key News & Latest Developments
Table 58. Astra Zeneca Company Summary
Table 59. Astra Zeneca Oral Antihypertensive Drug Product Offerings
Table 60. Astra Zeneca Oral Antihypertensive Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Astra Zeneca Key News & Latest Developments
Table 62. Daiichi Sankyo Company Summary
Table 63. Daiichi Sankyo Oral Antihypertensive Drug Product Offerings
Table 64. Daiichi Sankyo Oral Antihypertensive Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Daiichi Sankyo Key News & Latest Developments
Table 66. Takeda Company Summary
Table 67. Takeda Oral Antihypertensive Drug Product Offerings
Table 68. Takeda Oral Antihypertensive Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Takeda Key News & Latest Developments
Table 70. Actelion Company Summary
Table 71. Actelion Oral Antihypertensive Drug Product Offerings
Table 72. Actelion Oral Antihypertensive Drug Revenue (US$, Mn) & (2018-2023)
Table 73. Actelion Key News & Latest Developments
Table 74. United Therapeutics Company Summary
Table 75. United Therapeutics Oral Antihypertensive Drug Product Offerings
Table 76. United Therapeutics Oral Antihypertensive Drug Revenue (US$, Mn) & (2018-2023)
Table 77. United Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Oral Antihypertensive Drug Segment by Type in 2022
Figure 2. Oral Antihypertensive Drug Segment by Application in 2022
Figure 3. Global Oral Antihypertensive Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oral Antihypertensive Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Oral Antihypertensive Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oral Antihypertensive Drug Revenue in 2022
Figure 8. By Type - Global Oral Antihypertensive Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Oral Antihypertensive Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Oral Antihypertensive Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Oral Antihypertensive Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Oral Antihypertensive Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Oral Antihypertensive Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Oral Antihypertensive Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Oral Antihypertensive Drug Revenue Market Share, 2018-2029
Figure 16. US Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Oral Antihypertensive Drug Revenue Market Share, 2018-2029
Figure 20. Germany Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Oral Antihypertensive Drug Revenue Market Share, 2018-2029
Figure 28. China Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Oral Antihypertensive Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Oral Antihypertensive Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Oral Antihypertensive Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Novartis Oral Antihypertensive Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Oral Antihypertensive Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Johnson & Johnson Oral Antihypertensive Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sanofi Oral Antihypertensive Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Lupin Oral Antihypertensive Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Ranbaxy Laboratories Oral Antihypertensive Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Merck Oral Antihypertensive Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Astra Zeneca Oral Antihypertensive Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Daiichi Sankyo Oral Antihypertensive Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Takeda Oral Antihypertensive Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Actelion Oral Antihypertensive Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. United Therapeutics Oral Antihypertensive Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
